CD98, a heterodimer of an L-type amino acid transporter (LAT) and β-integrin1, has been implicated in the experimental colitis model that mirrors the clinical symptoms of inflammatory bowel disease (IBD). Here, SLC3A2 is linked to inflammatory bowel disease.